Navigation Links
ChemAxon and Patcore Agree Distribution of Patcore Products Beyond Japan

BUDAPEST, Hungary and TOKYO, August 21, 2013 /PRNewswire/ --

ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, and Patcore, a leading cheminformatics software and service company for pharmaceutical and life science industries, have agreed terms for the distribution of Patcore's CRAIS series of products globally excluding Japan.

Patcore's CRAIS product series are a set of innovative cheminformatics applications covering many common processes in life science research, including: compound registration, assay management, data browsing, collaborative interfaces, structure design and controlled substance compliance.

CRAIS Series

  • Checker - Controlled substances check system to reduce your daily compliance workload.
  • Transformer - Generates ideas for lead optimization based on an extensive bioisosteric knowledge base.
  • Browser - Powerful, user-friendly browser for chemical and biological data to inspire ideas
  • Registration - Make your compound registration smarter and maximize the data value
  • Assay - Standardized environment to register your assay results to a corporate database

The CRAIS products are based on ChemAxon's cheminformatics toolkits and offer users an "off the shelf" solution for common RnD processes, especially where high performance and integration within larger systems are essential.

About ChemAxon
ChemAxon is a leader in providing cheminformatics software platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries.  With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions that power modern cheminformatics and chemical communication.  The company is privately owned with European headquarters in Budapest, US East Coast headquarters in Cambridge, MA, and sales and support offices in Europe, Japan and across North America.

About Patcore Inc.

Patcore is based in TOKYO, providing cheminformatics software and services for Pharmaceutical and life science industries. Patcore was founded in 2003 and signed with ChemAxon in 2005 as an exclusive partner in Japan. Patcore successfully developed CRAIS series using ChemAxon technologies to help users to manage chemical and biological data more efficiently. These products are well accepted by many clients and Patcore has provided them for 15 of the top 20 pharmaceutical companies in Japan to date.

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Pearson Adds ChemAxons Suite of Chemistry Tools to MasteringChemistry Products
2. ChemAxons Extends PubChem Database With Crowd-Sourced Chemistry From the Web
3. ChemAxon Provides Chemistry Informatics Platform for the European Lead Factory
4. ChemAxon Major Software Release brings New Desktop, Web and Visualization Applications to Power Chemistry Decision Making
5. Schrödinger and ChemAxon Extend Partnership
6. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
7. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
8. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
9. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
10. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
11. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
Post Your Comments:
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... on behalf of the Toronto Stock Exchange, confirms that ... are no corporate developments that would cause the recent ... --> --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical ...
Breaking Biology Technology:
(Date:10/29/2015)... Va. , Oct. 29, 2015 Daon, ... today that it has released a new version of ... customers in North America have ... IdentityX v4.0 also includes a FIDO UAF certified ... are already preparing to activate FIDO features. These customers ...
(Date:10/27/2015)... -- In the present market scenario, security is one ... verticals such as banking, healthcare, defense, electronic gadgets, and ... secure & simplified access control and growing rate of ... bank accounts, misuse of users, , and so on. ... and smartphones are expected to provide potential opportunities for ...
(Date:10/26/2015)...  Delta ID Inc., a company focused on bringing ... devices, announced its ActiveIRIS® technology powers the iris recognition ... by NTT DOCOMO, INC in Japan ... to include iris recognition technology, after a very successful ... May 2015, world,s first smartphone to have this capability. ...
Breaking Biology News(10 mins):